Price
No data yet.
Social Signal Score
Analyst Ratings
33 analystsRevenue
$1.01B+246.10%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Joseph Hogan
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 20,290
- Beta
- 1.74
- Country
- US
- Piotroski score
- 8 / 9 (Strong)
- Altman Z-score
- 4.81
Financials
Revenue
$1.01B+246.1%Net Income
$135.04M+183.6%EBITDA
$170.07M+125.0%Free Cash Flow
$137.89M+106.5%EPS (diluted)
$1.90+227.6%Shares Outstanding (diluted)
71.02M-12.9%Operating Expenses
$504.43MCash & Debt
$1.14BReturn of Capital
$103.06MRevenue by Segment (annual)
$4.03BQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $4.03B | $410.35M | $5.66 |
| 2024 | $4.00B | $421.36M | $5.63 |
| 2023 | $3.86B | $445.05M | $5.82 |
| 2022 | $3.73B | $361.57M | $4.62 |
| 2021 | $3.95B | $772.02M | $9.78 |
| 2020 | $2.47B | $1.78B | $22.55 |
| 2019 | $2.41B | $442.78M | $5.57 |
| 2018 | $1.97B | $400.24M | $5.00 |
| 2017 | $1.47B | $231.42M | $2.89 |
| 2016 | $1.08B | $189.68M | $2.38 |
| 2015 | $845.49M | $144.02M | $1.80 |
| 2014 | $761.65M | $145.83M | $1.81 |
| 2013 | $660.21M | $64.30M | $0.80 |
| 2012 | $560.04M | $58.69M | $0.73 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from ALGN's reported EPS growth of 17.1% a year over 13 years.
- EPS in 5 years
- $12.46
- Implied price
- $348.75
- Return from $159.68
- 16.9% a year
To earn 15.0% a year on these assumptions you'd need to buy at $173.39 — today's price is already 7.9% below that.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 20 | 24 | 28 | 32 | 36 |
|---|---|---|---|---|---|
| 7.1% | -0.0% | 3.7% | 6.9% | 9.8% | 12.4% |
| 12.1% | 4.6% | 8.5% | 11.9% | 14.9% | 17.7% |
| 17.1% | 9.3% | 13.4% | 16.9% | 20.1% | 22.9% |
| 22.1% | 14.0% | 18.2% | 21.9% | 25.2% | 28.2% |
| 27.1% | 18.6% | 23.0% | 26.9% | 30.3% | 33.4% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
30+0.00%Social Signal Score
Mentions (46)
- Newsmarketbeat.com·3d ago·Negative
Align Technology Sees iTero Revenue Rebound in 2027 After Pricing Cuts Outlook Align Technology NASDAQ: ALGN expects its iTero scanner business to return to revenue growth in 2027 after pricing discounts and product mix contributed to a reduction in its 2026 sales outlook, executives said at the Jefferies Global Healthcare Conference in London.
View source ↗ - Newsbusinesswire.com·4d ago·Negative
Paul J. Clancy and Ian Bell to Join Align Technology Board of Directors TEMPE, Ariz. & SAN JOSE, Calif.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that its Board of Directors has appointed Paul J. Clancy, a biopharmaceutical executi…
View source ↗ - News (RSS)seekingalpha·5d ago·Positive
Align Technology, Inc. (ALGN) Presents at Jefferies Global Healthcare Conference 2026 Transcript
View source ↗ - Newsseekingalpha.com·5d ago·Positive
Align Technology, Inc. (ALGN) Presents at Jefferies Global Healthcare Conference 2026 Transcript Align Technology, Inc. (ALGN) Presents at Jefferies Global Healthcare Conference 2026 Transcript
View source ↗ - Newszacks.com·5d ago·Positive
Should You Continue to Hold ALGN Stock in Your Portfolio? Align Technology's Invisalign expansion, strategic alliances and strong stock gains support its prospects, but currency volatility and competition pose risks.
View source ↗ - News (RSS)kiplinger·6d ago·Positive
A Year-End Review Can Align Your Investments, Taxes, Goals A year-end portfolio review can reveal opportunities to improve your after-tax returns while keeping investment decisions aligned with your long-term goals.
View source ↗ - Newsprnewswire.com·11d ago·Negative
From Assembly Line to Test Room: Align Solves Complex Transport Challenge /PRNewswire/ -- Align Production Systems has successfully delivered a custom 50,000 lb capacity omnidirectional transporter for a leading engine manufacturer
View source ↗ - Newsbusinesswire.com·16d ago·Negative
Align Technology Announces $270 Million Accelerated Stock Repurchase Agreement TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it has entered into a new accelerated stock repurchase agreement (“ASR”) with Goldman Sachs …
View source ↗ - Newsseekingalpha.com·20d ago·Negative
…arket Share Align Technology remains the global leader in clear aligners but faces intensifying competition and declining pricing power, especially in North America. ALGN's US market is saturated, with falling shipments, utilization, and revenue per case; international growth is now the primary driver. Gross margins and brand strength are under pressure, with competitors gaining share through lower costs and improved aesthetics.
View source ↗ - Newsseekingalpha.com·23d ago·Positive
Align Technology: The Competitive Threat Has Eased, But Growth Remains A Concern Align Technology faces new catalysts, developments, and litigation progress that shift the investment landscape. Market sentiment currently appears to emphasize the risks associated with ALGN over potential opportunities. I now favor an intrinsic valuation approach based on future cash flows rather than relying solely on multiples or peer averages.
View source ↗ - Newszacks.com·24d ago·Neutral
ALGN Q3 Earnings & Revenues Beat, '26 Sales View Down, Stock Falls Align Technology's Q3 earnings and revenues beat estimates on higher aligner shipments, but a lowered 2026 sales outlook weighs on shares.
View source ↗ - News (RSS)fool·24d ago·Positive
Align (ALGN) Q3 2026 Earnings Call Transcript Record doctor submitters and aligner growth offset softer consumer spending headwinds.
View source ↗ - Newsmarketbeat.com·24d ago·Neutral
Align Technology Q3 Earnings Call Highlights Align Technology NASDAQ: ALGN reported third-quarter 2026 revenue of $1.015 billion, up 1.9% from a year earlier, as higher clear aligner volumes and international growth helped offset continued pressure in discretionary dental spending and capital-equipment purchasing.
View source ↗ - Newsseekingalpha.com·24d ago·Positive
Align Technology, Inc. (ALGN) Q3 2026 Earnings Call Transcript Align Technology, Inc. (ALGN) Q3 2026 Earnings Call Transcript
View source ↗ - News (RSS)seekingalpha·25d ago·Neutral
Align Technology, Inc. 2026 Q3 - Results - Earnings Call Presentation
View source ↗ - Newszacks.com·25d ago·Negative
Compared to Estimates, Align Technology (ALGN) Q3 Earnings: A Look at Key Metrics The headline numbers for Align Technology (ALGN) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
View source ↗ - Newszacks.com·25d ago·Positive
Align Technology (ALGN) Beats Q3 Earnings and Revenue Estimates Align Technology (ALGN) came out with quarterly earnings of $2.8 per share, beating the Zacks Consensus Estimate of $2.76 per share. This compares to earnings of $2.61 per share a year ago.
View source ↗ - Newszacks.com·26d ago·Negative
Is the Options Market Predicting a Spike in Align Technology Stock? Investors need to pay close attention to ALGN stock based on the movements in the options market lately.
View source ↗ - News247wallst.com·28d ago·Negative
Invisalign's Moment of Truth: Will International Growth Save ALGN on Oct 28? Align Technology (NASDAQ:ALGN | ALGN Price Prediction) reports third-quarter results on October 28. North America is flat and scanner revenue is shrinking, so I'll be watching whether double-digit international aligner growth can keep the Invisalign story moving.
View source ↗ - Newszacks.com·32d ago·Neutral
Align Technology (ALGN) Earnings Expected to Grow: Should You Buy? Align Technology (ALGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
View source ↗ - 4chan /biz/biz·33d ago·Negative
>>62803430 The Ultimate Advice: Justice & The Hierophant Your path to profitability relies entirely on systematic discipline. > Enforce strict rules: Establish hard stop-losses and automated take-profit levels (Justice). >Trust the institutions: Align your capital with major institutional flows, blue-chip foundations, and traditional economic cycles (The Hierophant). The era of easy money driven by market distortions is ending; the era of cold, calculated precision has arrived. If you would
View source ↗ - News (Marketaux)gurufocus.com·35d ago·Positive
Align Technology (ALGN) Wins European Patent Infringement Ruling Against Angelalign On October 18, 2026, Align [+263 characters]
View source ↗ - News (RSS)seekingalpha·35d ago·Neutral
Align Technology says European court finds Angelalign infringed patent
View source ↗ - Newsgurufocus.com·36d ago·Neutral
Align Technology Wins Significant Patent Infringement Case Against Angelalign at Unified Patent Court Align Technology, Inc. (âAlignâ) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign System of cl
View source ↗ - Newsbusinesswire.com·37d ago·Neutral
…icant Patent Infringement Case Against Angelalign at Unified Patent Court SAN JOSE, Calif. & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, welcomes the decision of the Unified Patent Court (“UPC”) finding that aligner systems incorporating Angelalign's Torque Ridges feature infringe Align's European Patent EP 2 237 738 B1, which relates to Alig…
View source ↗ - Newsbenzinga.com·38d ago·Negative
This Align Technology Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
View source ↗ - Newsglobenewswire.com·41d ago·Neutral
Sierra Dreams Makes Bedding Behave With a Patent-Pending System The Align System connects sheets, duvet covers, and inserts to address the everyday frustrations traditional bedding leaves unsolved. RENO, Nev. , Oct. 12, 2026 (GLOBE NEWSWIRE) -- Sierra Dreams, a bedding innovation company founded by a team of entrepreneurs led by product developer Zach Osness, today announced the introduction of its patent pending Align System, a connected bedding solution designed to address everyday frustration
View source ↗ - News (RSS)seekingalpha·48d ago·Neutral
Align Technology hit as appeals court revives dental aligners antitrust claims
View source ↗ - News (RSS)zerohedge·48d ago·Neutral
…ed and elevated spending on AI infrastructure (Alphabet unchanged, Amazon -0.1%, Apple -0.2%, Meta -0.2%, Microsoft +0.4%, Tesla -0.3%) Align Technology Inc. shares (ALGN) are down 2.8% after Evercore ISI downgraded the medical-device company to inline from outperform, writing that “the dental macro picture has meaningfully weakened.” Alvotech shares (ALVO) jump 8% after the US FDA approved additional US manufacturing capacity for Simlandi, the biotech’s biosimilar to Humira. CH Robinson Worldwi…
View source ↗ - Newszacks.com·51d ago·Neutral
Will Align Technology (ALGN) Beat Estimates Again in Its Next Earnings Report? Align Technology (ALGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
View source ↗ - Newszacks.com·51d ago·Positive
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
View source ↗ - Newsbusinesswire.com·55d ago·Neutral
…lign Technology Launches “SHIFT Happens” U.S. Campaign to Educate Adults About Lifelong Tooth Movement TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the launch of SHIFT Happens, a new consumer campaign designed to help Invisalign-tr…
View source ↗ - News (RSS)yahoo·65d ago·Neutral
Align Technology Sees Invisalign Growth Runway Despite Consumer Headwinds
View source ↗ - Newsmarketbeat.com·65d ago·Neutral
Align Technology Sees Invisalign Growth Runway Despite Consumer Headwinds Align Technology NASDAQ: ALGN sees continued growth potential for Invisalign clear aligners in the United States and internationally despite a challenging consumer environment, Chief Financial Officer John Morici said during a Baird investor conference.
View source ↗ - Newsseekingalpha.com·68d ago·Positive
Align Technology, Inc. (ALGN) Presents at 2026 Global Healthcare Conference Transcript Align Technology, Inc. (ALGN) Presents at 2026 Global Healthcare Conference Transcript
View source ↗ - Newszacks.com·69d ago·Neutral
Should You Continue to Hold ALGN Stock in Your Portfolio? Align Technology expands Invisalign and digital dentistry adoption as iTero gains traction, but weak capital spending and currency volatility remain risks.
View source ↗ - News (RSS)investing·75d ago·Positive
Align Technology options: bullish $220 call dominates flow as ALGN stock slides
View source ↗ - Newsbusinesswire.com·83d ago·Negative
Quentin Blackford to Join Align Technology Board of Directors TEMPE, Ariz. & SAN JOSE, Calif.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that its Board of Directors has appointed Quentin Blackford, President and Chief Executive Offi…
View source ↗ - News (RSS)investing·93d ago·Neutral
Aligned Launches $ALIGN, the Native Token of Its Full Ethereum Stack
View source ↗ - News (RSS)zerohedge·95d ago·Neutral
7 Federal Agencies & Big Pharma Quietly Built A Pandemic-Industrial Complex 7 Federal Agencies & Big Pharma Quietly Built A Pandemic-Industrial Complex Authored by Jon Fleetwood via substack, Nearly 14 years before COVID-19, HHS created the Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) and centralized federal health, biomedical, regulatory, homeland-security, and military functions around a government-directed countermeasure pipeline. Creating what this website refers to as
View source ↗ - Newsgurufocus.com·97d ago·Positive
Align Technology Inc (ALGN) Stock Down 5.6% -- Now Undervalued? GF Score: 89/100 On August 17, 2026, Align Technology Inc (ALGN) shares fell 5.6%, bringing the current price to $171.16. The stock has experienced a 52-week range of $122.00 to
View source ↗ - News (RSS)seekingalpha·97d ago·Positive
Align Technology: DCF Signals Overvaluation Despite Long-Term Growth Potential
View source ↗ - News (Marketaux)seekingalpha.com·97d ago·Positive
Align Technology: DCF Signals Overvaluation Despite Long-Term Growth Potential I am assigning a hold rating to Alig[+320 characters]
View source ↗ - Newszacks.com·100d ago·Positive
Should Investors Buy Align as Growth Meets Valuation and Demand Risks? ALGN's record Clear Aligner growth and global adoption support the bull case, but demand softness and scanner pricing pressure keep investors cautious.
View source ↗ - News (RSS)financialpost·102d ago·Neutral
Align Technology Prevails in China Patent Infringement Action Against Angelalign SAN JOSE, Calif. & TEMPE, Ariz. — Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, today announced that the Jinan Intermediate People’s Court in China issued a judgment in favor of Align in a patent infringement action against Angelalign Technology’s […]
View source ↗ - Newsbusinesswire.com·103d ago·Neutral
Align Technology Prevails in China Patent Infringement Action Against Angelalign SAN JOSE, Calif. & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. ("Align") (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, today announced that the Jinan Intermediate People's Court in China issued a judgment in favor of Align in a patent infringement action against Angelalign Technology's operating subsidiaries in China
View source ↗
Earnings
Wed, Feb 3(in 2 months)
Consensus estimate $3.05 per share
Typical surprise +7.0% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Oct 28$2.80 vs $2.77beat
- Wed, Jul 29$2.64 vs $2.62beat
- Wed, Apr 29$2.58 vs $2.30beat
- Wed, Feb 4$3.29 vs $2.99beat
- Wed, Oct 29$2.61 vs $2.40beat
- Wed, Jul 30$2.49 vs $2.57miss
Estimates and results for ALGN via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by ALGN officers and directors.
- Bought
- $1.0m
- Sold
- $1.5m
2 trades
1 trade
- Morici Johnsold
- Hogan Joseph Mbought
- Coletti Julie Annbought
97 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Ro Khannahouse · CA17 · disclosed Oct 9, 2026 (28d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Oct 9, 2026 (35d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Feb 10, 2026 (12d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Oct 22, 2025 (41d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Sep 15, 2025 (42d later)Buy$1,001 - $15,000
- Robert P. Bresnahanhouse · PA08 · disclosed May 8, 2025 (30d later)Sell$1,001 - $15,000
- Robert P. Bresnahanhouse · PA08 · disclosed Mar 28, 2025 (31d later)Buy$1,001 - $15,000
- Gilbert Cisneroshouse · CA31 · disclosed Mar 7, 2025 (9d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Oct 8, 2024 (29d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Oct 8, 2024 (29d later)Buy$1,001 - $15,000
- Josh Gottheimerhouse · NJ05 · disclosed Jun 8, 2024 (19d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Mar 6, 2024 (22d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Feb 5, 2024 (26d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Dec 6, 2023 (33d later)Sell$1,001 - $15,000
- Josh Gottheimerhouse · NJ05 · disclosed Nov 11, 2023 (15d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 8, 2023 (37d later)Buy$1,001 - $15,000
- Daniel Scott Sullivansenate · AK · disclosed Sep 22, 2023 (31d later)Sell$1,001 - $15,000
- Daniel Scott Sullivansenate · AK · disclosed Sep 18, 2023 (27d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Sep 6, 2023 (8d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Aug 7, 2023 (10d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
